Clinical Trial Update: Long-term Safety, Tolerability and Efficacy of Omalizumab in Japanese Children [Phase 3]

View source ↗

Summary

This update presents long-term safety, tolerability, and efficacy data for omalizumab in Japanese children with allergic asthma from a Phase 3 trial. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Asthma

Drugs mentioned

• Omalizumab (Omalizumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Allergic Asthma | Phase 3 | Status: COMPLETED